Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ESS in Anemia of Chronic Disease
NCT01846689Phase 3Unknown
- Sponsor
- Targeted Medical Pharma, Inc.
- Start
- Jun 2013
- Primary completion
- Aug 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ESS in anemia of chronic disease (ACD), sponsored by Targeted Medical Pharma, Inc.. Status: unknown.
02
Drugs
ESS
03
Conditions
anemia of chronic disease (ACD)
Beyond the preview
Go deeper on NCT01846689.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01846689.